Return to homepagePandemic Pact

Clinical characterisation: Does SARS-CoV-2 injure the brain?

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: C19-IUC-031

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    UK Research and Innovation (UKRI)

  • Principal Investigator

    Prof. Henrik Zetterberg

  • Research Location

    United Kingdom

  • Lead Research Institution

    UK Dementia Research Institute

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Clinical characterisation of the neurological and cognitive effects of SARS-CoV-2 linked brain injury, by examining CNS effects of SARS-CoV-2 in an international collaborative effort to identify the frequency of such symptoms and how these can be detected, predicted, monitored and, potentially, treated. Project will include comparing cerebrospinal fluid/blood biomarker profiles for neuronal injury and neuroinflammation between COVID-19 positive patients with and without neurological symptoms.